Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Cash (2020 - 2025)

Biofrontera (BFRI) has 6 years of Change in Cash data on record, last reported at -$3.8 million in Q3 2025.

  • For Q3 2025, Change in Cash fell 153.78% year-over-year to -$3.8 million; the TTM value through Sep 2025 reached $544000.0, up 199.09%, while the annual FY2024 figure was $4.6 million, 128.76% up from the prior year.
  • Change in Cash reached -$3.8 million in Q3 2025 per BFRI's latest filing, down from $5.5 million in the prior quarter.
  • Across five years, Change in Cash topped out at $22.8 million in Q4 2021 and bottomed at -$10.4 million in Q4 2022.
  • Average Change in Cash over 5 years is -$245263.2, with a median of -$1.6 million recorded in 2021.
  • The widest YoY moves for Change in Cash: up 870.46% in 2025, down 266.53% in 2025.
  • A 5-year view of Change in Cash shows it stood at $22.8 million in 2021, then plummeted by 145.37% to -$10.4 million in 2022, then soared by 79.93% to -$2.1 million in 2023, then surged by 245.84% to $3.0 million in 2024, then plummeted by 226.06% to -$3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$3.8 million in Q3 2025, $5.5 million in Q2 2025, and -$4.1 million in Q1 2025.